Status:

UNKNOWN

rTMS in Managing Individuals With Chronic Low Back Pain and Comorbid Insomnia

Lead Sponsor:

The Hong Kong Polytechnic University

Conditions:

Chronic Pain

Insomnia

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This pilot randomized controlled trial (RCT) aims to investigate the feasibility and efficiency of delivering different rTMS protocols in individuals with CLBP and insomnia. Participants will be rando...

Detailed Description

Sleep disturbance exacerbates pain perception, disability, and poor prognosis in individuals with chronic low back pain (CLBP). A recent systematic review demonstrated that improvements in sleep distu...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • participants aged between18 and 65 years;
  • willing to participate in the study and randomization;
  • having stable pharmacological or nonpharmacological treatments for pain or sleep at least one month prior to study participation;
  • having CLBP (defined as pain between 12 ribs and gluteal crease with or without leg pain that has persisted for at least three months)
  • diagnosing insomnia using the Brief Insomnia Questionnaire (BIQ) based on the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5)
  • Exclusion Criteria
  • specific causes of CLBP (e.g., spondylosis, spondyloarthropathy, or vertebral fracture);
  • pregnancy or nursing;
  • previous spinal surgery;
  • inflammatory or autoimmune diseases;
  • other sleep disorders (e.g., sleep apnea or restless leg);
  • presence of severe psychopathologies, neurological, or physical disease directly related to the onset of insomnia (e.g., depression, substance abuse, or alcohol abuse);
  • severe dependence on hypnotic drugs;
  • concurrent receipt of new treatments outside the scope of the study;
  • contraindications to use rTMS (e.g., severe head trauma, intracranial hypertension, implanted ferromagnetic devices, history of epilepsy).

Exclusion

    Key Trial Info

    Start Date :

    December 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 31 2025

    Estimated Enrollment :

    45 Patients enrolled

    Trial Details

    Trial ID

    NCT06158321

    Start Date

    December 1 2024

    End Date

    August 31 2025

    Last Update

    December 6 2023

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.